Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind study of evocalcet vs cinacalcet in secondary hyperparathyroidism in maintenance dialysis
CTR20190245Phase 3Active
- Sponsor
- Kyowa Kirin
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Kyowa Kirin. Started Feb 2019; status: active.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on CTR20190245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190245.